Based on the provided data, the turnover per employee in the biotechnology research and experimental development sector in Spain shows a slight but consistent decline from 2024 through 2028. The value is projected to decrease from 40.7 thousand euros in 2024 to 40.4 thousand euros in 2028. This data implies a modest annual drop in turnover per employee.
The year-on-year percentage variations are minimal: -0.24% in 2025, -0.25% in 2026, -0.25% in 2027, and 0% in 2028. Over the last two years, this represents a small overall decline, highlighting a consistent but slow reduction in turnover per employee. The Compound Annual Growth Rate (CAGR) for the period 2024-2028 is approximately -0.18%, showing an average annual decrease.
Future trends to watch for include potential advancements in biotechnology that might boost efficiency and turnover. Additionally, policy changes or increased investment in R&D activities could alter these projections, possibly reversing the trend. Keeping an eye on economic factors and competitive dynamics will be crucial for a more accurate forecast.
